Single chain Fv antibodies for targeting cancer therapy.

被引:0
|
作者
Begent, RHJ [1 ]
Chester, KA [1 ]
机构
[1] ROYAL FREE HOSP, SCH MED, TARGETING & IMAGING GRP, LONDON NW3 2PF, ENGLAND
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:SI113 / SI113
页数:1
相关论文
共 50 条
  • [1] Single-chain Fv antibodies for targeting cancer therapy
    Begent, RHJ
    Chester, KA
    BIOCHEMICAL SOCIETY TRANSACTIONS, 1997, 25 (02) : 715 - 717
  • [2] Single-chain Fv Antibodies for Targeting Neurodegenerative Diseases
    Chia, Kin Yen
    Ng, Khuen Yen
    Koh, Rhun Yian
    Chye, Soi Moi
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2018, 17 (09) : 671 - 679
  • [3] HLA DR-directed bispecific single-chain Fv antibodies for lymphoma therapy
    Y Wachter
    J Brünke
    S Schuster
    K Barbin
    M Peipp
    T Valerius
    M Gramatzki
    G Fey
    R Repp
    Cancer Cell International, 4 (Suppl 1)
  • [4] Targeting DNA repair in cancer therapy.
    D'Andrea, Alan D.
    CLINICAL CANCER RESEARCH, 2018, 24 (01) : 17 - 17
  • [5] The use of single chain Fv as targeting agents for immunoliposomes: an update on immunoliposomal drugs for cancer treatment
    Cheng, W. W.
    Allen, T. M.
    EXPERT OPINION ON DRUG DELIVERY, 2010, 7 (04) : 461 - 478
  • [6] Ras and p53 intracellular targeting with recombinant single-chain Fv (scFv) fragments: A novel approach for cancer therapy?
    Cochet, O
    Gruel, N
    Fridman, WH
    Teillaud, JL
    CANCER DETECTION AND PREVENTION, 1999, 23 (06): : 506 - 510
  • [7] Targeting the ATF-1/CREB transcription factors by single chain Fv fragment in human melanoma: Potential modality for cancer therapy
    Jean, D
    Bar-Eli, M
    CRITICAL REVIEWS IN IMMUNOLOGY, 2001, 21 (1-3) : 275 - 286
  • [8] Generating improved single-chain Fv molecules for tumor targeting
    Adams, GP
    Schier, R
    JOURNAL OF IMMUNOLOGICAL METHODS, 1999, 231 (1-2) : 249 - 260
  • [9] Single chain Fv antibodies against syncytin and its receptor RDR
    Drewlo, S
    Haas, E
    Rüben, A
    Zahn, U
    Pötgens, AJG
    PLACENTA, 2005, 26 (8-9) : A70 - A70
  • [10] Targeting the Hippo pathway for candidate cancer therapy.
    Hong, Wanjin
    MOLECULAR CANCER RESEARCH, 2020, 18 (08) : 16 - 17